Research Article
The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19
Table 2
Time segment and prognosis of AMI inpatients.
| | 2019 (n = 256) | 2020 (n = 207) | |
| S2FMC time (minutes) | 309 (84.25–1267.50) | 251 (80–1080) | 0.552 | Conservative therapy (N) | 50 | 34 | 0.389 | Thrombolytic therapy (N) | 1 | 2 | 0.443 | Invasive treatment (N) | 205 | 171 | 0.488 | LVEF | 62 (52.5–67.5) | 62 (54.5–67.0) | 0.826 | In-hospital mortality (%) | 3.9 | 3.4 | 0.765 | STEMI in-hospital mortality (%) | 3.9 | 3.3 | 0.822 | NSTEMI in-hospital mortality (%) | 3.9 | 3.6 | 0.941 | Hospitalization length (days) | 7 (5–9) | 7 (5–8.25) | 0.410 | STEMI hospitalization length (days) | 7 (5.25–9) | 6 (5–8) | 0.122 | NSTEMI hospitalization length (days) | 7 (5–9) | 7 (5–9) | 0.903 | Patients admitted within 12 hours of onset (%) | 73.4 | 68.1 | 0.335 |
|
|
AMI: acute myocardial infarction; S2FMC: symptoms to the first medical contact; STEMI: ST-elevation myocardial infarction; NSTEMI: non-ST-elevation myocardial infarction; LVEF: left ventricular ejection fraction; N: number.
|